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1.1 Abstract 
Tissue engineering scaffolds for nerve regeneration, or artificial nerve conduits, are 
particularly challenging due to the high level of complexity the structure of the nerve 
presents. The list of requirements for artificial nerve conduits is long and includes the ability 
to physically guide nerve growth using physical and chemical cues as well as electrical 
stimulation. Combining these characteristics into a conduit, while maintaining 
biocompatibility and biodegradability, has not been satisfactorily achieved by currently 
employed fabrication techniques. Here we present a method combining pultrusion and wet-
spinning techniques facilitating incorporation of pre-formed filaments into ionically 
crosslinkable hydrogels. This new biofabrication technique allows the incorporation of 
conducting or drug-laden filaments, controlled guidance channels and living cells into 
hydrogels, creating new improved conduit designs. 
1.2 Introduction 
Manufacturing complex scaffolds which truly mimic natural tissue is one of the greatest 
ongoing challenges for biofabrication [1]. Critically, these structures must match the intrinsic 
geometry and functionality of the body’s environment to develop treatments for conditions 
where artificial tissues or structures are essential [1, 2]. Engineering scaffolds for 
regenerative peripheral nerve applications is particularly difficult as many biological, 
physical, and chemical requirements need to be fulfilled [3]. This challenge has been outlined 
in a number of reviews which detail required characteristics to build an ideal conduit and 
facilitate nerve regeneration [4-6]. The ideal conduit that has been proposed needs to be 
biocompatible, biodegradable, and have appropriate porosity to allow exchange of fluids, 
gasses and nutrients, while preventing unwanted cells from penetrating into the structure [7]. 
Strategies for these conduits also include controlled drug and growth factor release to provide 
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chemical cues to the regenerating nerve contributing to the ideal environment for regrowth 
[8]. Integrating conductivity within the conduit has additionally been suggested as a way to 
facilitate electrical stimulation of nerve cells, which has been shown to have positive effects 
on the regeneration process [9]. Further, to structurally mimic the nerve and provide guidance 
to the regenerating cells small channels or lumens need to be incorporated into the design 
[10]. Finally, inclusion of supportive cells like Schwann cells can further provide guidance 
and chemical stimulation by releasing growth factors and hence improve the regeneration of 
the nerve [8].  
Efforts to address these requirements have often focused on developing material systems to 
meet one or two characteristics of the ideal conduit at a time and assembling them into a final 
structure. For instance, by electrospinning drug-loaded silk mats and manually rolling them 
into a tube, Dinis et al. [11] fabricated a slow release, multi-luminal, but non-degradable 
nerve conduit that closely mimicked the mechanical properties and morphological structure 
of nerves. Abidian et al. [12] manufactured a partially-degradable, conducting, single lumen 
3D hydrogel conduit in a multi-step approach utilizing sputter coating, dip coating and 
electro-polymerization, as well as chemical treatments to dissolve parts of the construct, 
creating the inner lumen. A conducting pattern was created by manually covering parts of the 
structure with masking tape before electrically polymerizing a conducting polymer onto the 
surface. Lee et al. [13] implanted a non-degradable, porous, collagen coated electrode-
conduit system into a rat model and delivered electrical stimulation to the regenerating nerve. 
Using a multi-step approach our group has previously fabricated a conduit combining 
biodegradability, precise pore sizes, internal guidance and (uncontrolled) growth factor 
delivery (Quigley et al. [14]). This conduit was produced using sequential fabrication and 
assembly processes, including wet spinning, electrospinning, knitting and drop-casting of 
multiple components before manual assembly.  
The fabrication of the examples above required multiple production steps and manufacturing 
technologies and significant manual assembly. So far the design and manufacture of a 
universal platform able to integrate the ideal features into a single structure has been limited 
by currently employed fabrication techniques. A less complicated approach would be 
desirable to increase quality and repeatability in production of the conduits and reduce the 
complexity and costs of fabrication without compromising on the conduits performance.  
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Reduced to their most basic morphological features, nerves and nerve guides or conduits are 
tubular structures and several leading fabrication approaches have been used to create 
scaffolds that conform to this general form [15-17]. Wet-spinning is a well-established, 
versatile fabrication technique that has been used to produce long homogenous bio-fibres 
with diameters ranging from nanometres to millimetres [18-21]. During wet-spinning, the 
spinning solution is passed through a nozzle or spinneret and into a bath that contains the 
material’s specific coagulation agent. Fibres either remain in the bath to coagulate, or more 
commonly are gathered on a collector drum after coagulation. The drum can also be used to 
draw the fibres during the spinning process, resulting in smaller fibre diameters and increased 
mechanical properties in some materials [22]. The cross-sectional shape and size of the fibre 
are mainly dictated by dimensions of the extrusion nozzle, the extrusion rates used and the 
post-spinning treatment applied to the fibre.  
Commonly used materials for wet spinning bio-fibres are ionically crosslinkable hydrogels 
like sodium alginate or gellan gum. These materials can easily be wet-spun into fibres using 
calcium containing coagulation baths. Fibres produced in this way show biocompatibility 
with a range of cell types which are in contact with or encapsulated into the fibres. Alginate 
in particular, has been used frequently to produce viable-cell laden fibres due in part to the 
mild conditions under which fibres can be produced (aqueous systems, neutral pH, no harsh 
solvents or high temperatures)[23, 24]. However, these hydrogels alone cannot achieve all the 
features needed for an ideal nerve guide, as they lack inherent controllable drug or growth 
factor release as well as the presence of electrical conductivity in the bulk material for 
stimulation. As such, alginates are often combined with other materials such as polylactic 
acid and organic electrically conducting materials like conducting polymers or graphenes, 
which show excellent drug delivery profiles and electrical conductivity [25-29]. These 
secondary components are easily produced in different shapes, including films, particles and 
fibres.   
In order to address the lack of inherent electrical conductivity and ability to deliver drugs in a 
controlled fashion, a novel technique has been developed, which combines the processability 
of ionically crosslinked hydrogels with the desired properties of secondary material 
components by controllably embedding pre–formed filaments into hydrogels. This method 
allows not only the encapsulation of reliably conducting or drug releasing elements, but also 
enables encapsulation of living cells into the 3D system. Here we present the design, testing 
and optimization of the system and also showcase its flexibility by producing fibrous 3D 
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hydrogels containing filaments of different materials, morphologies and geometries, placed 
controllably into a range of positions and configurations. Furthermore, we investigate the 
production of homogenous channels in the hydrogels by mechanically removing the 
encapsulated filaments as well as backfilling these channels with other liquids. The 
cytocompatibility of the fabrication method and the resulting 3D structures were also 
investigated by extruding living cells directly into the 3D structure and analysing their 
viability at different time points after production. 
1.3 Experimental 
1.3.1 Materials 
Medium viscosity alginate (AlgM, Sigma-Aldrich, Australia) and ultrapure, low viscosity 
alginate (AlgL, Pronova, USA) were used to encapsulate filaments into fibrous 3D structures. 
Alginate stock solutions were prepared by dissolving the respective alginate powder in water 
at 20 mg ml
-1
. Stock solutions were kept at 4°C and used within 8 weeks of preparation. 
Spinning solutions containing less than 20 mg ml
-1
 alginate were prepared by diluting from 
stock solutions. 90 mM calcium chloride (CaCl2, ChemSupply, Australia) was used as the 
coagulation solution for all experiments. 
The filaments used are summarized in Table 1 and filament specific dimensions, shapes, 
properties (roughness, hydrophobicity) and manufacturers are detailed. To assist the reader 
abbreviations for the filaments referenced throughout the article are also outlined. 
Table 1: Summary of abbreviations, materials, diameters and manufacturers of filaments used as part of this study. 
Abb. Material Diameter Properties Manufacturer 
SS50 316 stainless steel 50 µm circular, very smooth, hydrophilic Goodfellow, UK 
SS150 316 stainless steel 150 µm circular, very smooth, hydrophilic Goodfellow, UK 
Fe65 Iron 65 µm circular, smooth, hydrophilic Goodfellow, UK 
PLA100 polylactic acid  115 µm mostly circular, smooth, hydrophilic made in-house 
PLA+ polylactic acid 100 µm star shaped, smooth, hydrophobic made in-house 
rGO-PPy 80% graphene 20% polypyrrole  150 µm mostly circular, rough, very hydrophobic made in-house 
CFT carbon fibre tow - bundle, rough, hydrophobic SGL group, Germany 
Nylon nylon fishing line 280 µm circular, very smooth, very hydrophobic Jarvis Walker, Australia 
 
Commercially available filaments were used as received, with exception of CFT which was 
manually pulled into small bundles containing 20 – 50 fibres. PLA and rGO-PPy composite 
fibres were produced in-house using either melt or wet-spinning methods respectively. PLA 
fibres were produced by means of a counter rotating micro twin-screw extruder (Burrell 
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Scientific, USA). The extruded filaments were drawn at ambient temperature to a diameter of 
100 - 150 µm and collected on a winder.  
rGO-PPy composite fibres were produced by using a rotational wet-spinning approach as 
described in Schirmer et al. [30]. The spinning solutions were prepared by adding PPy 
nanoparticles to graphene oxide dispersed in water at a weight ratio of 80% graphene and 
20% PPy particles. Fibres were extruded through a 19 gauge single lumen metal spinneret at 
a rate of 25 ml h
-1
. A coagulation bath was used to form the fibres which contained a mixture 
of ethanol, acidic reducing agent and calcium chloride. Fibres remained in the coagulation 
bath at 80°C for 12 h; then were washed, collected and dried in air. 
1.3.2 Fabrication Method 
The setup for the customized wet-spinning based pultrusion method is illustrated in Figure 
1A. Purpose-built, custom spinnerets with continuous through-channels to feed and 
encapsulate filaments are core to the method. A transverse section of an example of a 
spinneret accommodating four filaments is shown in Figure 1B. Filaments are passed straight 
through the spinnerets, while a hydrogel is fed into the main barrel through a separate port, 
resulting in the encapsulation of the filaments. A dual syringe pump (Gemini 88, KD 
Scientific) was installed vertically to extrude the spinning solutions at precisely controlled 
rates through the spinneret into the coagulation bath. To allow formation of the 3D structure, 
the coagulation bath was secured on a motorised linear stage to move the bath in a fixed 
plane relative to the spinneret at variable controllable speeds. Operation of the 24 V linear 
stage (Cool Muscle RCM1) was managed through proprietary control software (Cool Works 
Lite 4.1.4) that provides an interface to define parameters including, position, acceleration, 
and velocity. 
Before the extrusion process was initiated, filaments were threaded through the spinneret, 
aligned, and secured within the coagulation bath using custom 3D printed titanium holders. 
The spinneret was then connected to the syringe containing the hydrogel solution and placed 
in the first position in the syringe pump. If an additional spinning solution was required, it 
was placed into the second position in the syringe pump and connected to the spinneret via a 
piece of tubing, as shown in Figure 1A and Figure 1D respectively. 
Once these steps were completed the filament was put under tension and the coagulation 
solution was filled into the bath until the horizontal barrel of the spinneret was fully 
submerged. 
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Figure 1: Schematic setup of filament encapsulating extrusion system (A). B: Exemplary transverse section of spinneret. Insets show 
the pultrusion process is illustrated in Figure 2. The procedure is initiated by starting the syringe pump and pumping the hydrogel 
solution from the syringe through the spinneret and into the coagulation bath (Figure 2A1-3). Once the hydrogel is observed to exit 
the spinneret, the stage is set into motion, starting with the end of the coagulation bath close to the front tip of the spinneret and 
moving to the opposite side. As the coagulation bath is moved away from the spinneret, the gel was continually extruded, 
surrounding the installed filament/s, forming a structure which encapsulates the filament/s (Figure 2B1-2). The extrusion and stage 
movement continue until the back end of the spinneret has reached the end of the coagulation bath, or when the desired length of 
extrusion has been reached. The extruded structure was then removed from the set-up by severing at the attached end and in front 
of the spinneret (Figure 2C1-3). 
The pultrusion process is illustrated in Figure 2. The procedure is initiated by starting the syringe 
pump and extruding the hydrogel solution from the syringe through the spinneret and into the 
coagulation bath (Figure 2A1-A3). Once the hydrogel exits the spinneret, the stage is set into 
motion, moving the coagulation bath, which in turn moves the spinneret horizontally through the 
coagulation solution from one end of the bath to the other, at a controlled rate. As the coagulation 
bath is moved, the gel is continually extruded, surrounding and encapsulating the installed 
filament/s (Figure 2B1-B2). The extrusion and stage movement continue until the back end of the 
spinneret has reached the end of the coagulation bath, or when the desired length of extrusion has 
been achieved. The extruded structure is then removed from the set-up by severing the end 
attached to the spinneret (Figure 2C1-C3). 
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Figure 2: Illustration of the extrusion process. A: The spinning solution is pushed through the spinneret and into the coagulation 
bath. B: While the extrusion of the spinning solution continues, the bath starts moving away from the spinneret, resulting in the 
hydrogel to be extruded around the filament. C: When the extrusion is completed, both stage and syringe pump are stopped and the 
extruded structure removed from the bath.  
 
A critical part of the assembly is the exact positioning of the filaments, which need to be 
reliably aligned with the spinneret and held under tension throughout the pultrusion process 
to ensure even encapsulation. This was achieved by designing a custom filament holder as 
shown in Figure 3: an array of fine holes (Ø 400 µm) allow filament positioning in different 
configurations to enable the use of the holder with a range of commercial and custom 
spinnerets. Larger holes were incorporated into the design to allow unimpeded fluid flow 
through the holder and prevent any baffling effect during the extrusion process. The holder 
rests on the side wall of the coagulation bath anywhere along its length and is secured in 
place by M4 screws. The filament holders were 3D printed (titanium 6-4, powder of spherical 
particles 20-60 µm distribution in 25 µm layers) using a SLM-50 metal additive fabrication 
system (Realizer, Germany). Post-treatment of the printed parts to achieve a smoothened 
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surface finish involved the removal of support material, bead blasting (20 µm glass beads) 
and bath sonication in water to remove loose material.  
 
 
Figure 3: Rendered view (A) and technical drawing (B) of filament holder including enlarged detail view of positioning of holes 
which hold the filaments in place. All measurements are in mm.  
The coagulation bath was folded and welded from stainless steel sheets to a length of 
750 mm, with a width and depth of 25 mm. The length of the bath was chosen to use the 
entire moving range of the linear stage in order to maximize the length of filament that could 
be encapsulated in one extrusion event (65 cm). The width and depth were kept to a 
minimum to reduce the amount of coagulant required to fill the bath, in order to reduce the 
weight that has to be moved.  
1.3.3 Controllability, Reproducibility and Versatility 
Controllability and reproducibility of the system were analysed by the production of fibres 
from AlgM extruded around Fe65 at different combinations of extrusion rates and stage speeds. 
The resulting fibre diameters extruded under the same conditions were compared within 
batches as a measure of reproducibility and between fabrication runs to assess the instruments 
limitations and flexibility with respect to the hardware. 
To analyse the response of the system to changing stage speeds and extrusion rates different 
thickness gradients were produced. Gradual diameter gradients along the gel structure were 
produced by extrusion around Fe65 while manually varying the extrusion rates between 0.1 – 
0.8 ml min
-1
 with a constant stage speed (4.8 mm sec
-1
). Abrupt changes in diameter were 
produced by varying the stage speeds during the extrusion process between 3.6 – 
24.1 mm sec
-1
, while keeping the extrusion rate constant 0.3 ml min
-1
. 
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To investigate the versatility of the method, a variety of spinneret designs were utilized to 
fabricate structures with different filament layouts using a range of filament sizes (50 – 
290 µm diameter), shapes and materials.  
1.3.4 Incorporation of Living Cells 
To incorporate cells into the conduits, the setup was sterilized and moved into a Class II 
biosafety cabinet. Instrumentation not suitable for autoclaving (syringe pump, power supply, 
stage, tubing) was sterilized using 70% ethanol. All other parts (coagulation bath, spinneret, 
holders, SS wires) were autoclaved at 121°C for 20 minutes. 90 mM calcium chloride 
coagulation solution and AlgL spinning solution diluted to 1% were filter sterilized using 
0.2 µm sterile cellulose filters (Merck Millipore, Australia).  
The extrusion process was performed at room temperature. To decrease the period of time 
cells were exposed to ambient temperatures and maintain high viability, cells were suspended 
in gels warmed to 37°C shortly before pultrusion and transferred into media warmed to 37°C 
immediately after finishing the extrusion process. 
A neuronal PC12 cell line used in the work, was cultured by splitting routinely every two to 
three days when semi-confluent using 0.05% Trypsin (Life Technologies, Australia) 
following the protocols from the American Type Culture Collection (ATCC). Cells were 
maintained in proliferation medium containing Dulbecco’s Modified Eagle’s Medium 
(DMEM, Invitrogen, Australia), 10% horse serum (Sigma), 5% fetal bovine serum (FBS, 
Bovogen) and 2 mM Glutamine (Life Technologies).  
For incorporation in the extrusion process, PC12 cells were counted and resuspended in 
1% AlgL at a density of 5 x 10
5
 cells ml
-1
. Cell-laden gel was pipetted up and down several 
times to ensure that the cells were well dispersed within the gel, before it was being 
transferred into a sterile syringe. 
For viability studies cell-laden fibres were extruded using a four lumen spinneret and four 
SS50 filaments with the stage speed set to 4.8 mm sec
-1
 and an extrusion rate of 0.5 ml min
-1
. 
Cells in fibres were stained for live and dead cells (described in Section 1.3.5) at 3 h, 24 h 
and 4 days after extrusion. 
For fabrication of 3D gel fibres containing cells in a middle lumen and four SS50 filaments, 
cells were suspended in a gellan gum microgel, which was prepared based on a modified bio-
ink protocol [31]. Briefly, 0.5 ml of 1% filter sterilized gellan gum (Gelzan CM, Sigma-
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Aldrich) solution and 9.5 ml DMEM were heated separately to 80°C before being mixed 
together in a 50 ml centrifugation tube and vortexed until cooled to room temperature. The 
resulting gellan gum microspheres keep cells homogenously suspended in solution, which 
overcomes cell settling issues during the extrusion process. Cells were suspended in gellan 
gum microgel at a density of 1.5 x 10
6
 cells ml
-1
 and extruded through the innermost needle at 
a rate of 0.05 ml min
-1
. A 1% AlgL solution was fed into the outer needle of the spinneret at a 
rate of 0.8 ml min
-1
, with the stage speed set to 4.8 mm sec
-1
. 
For fabrication of triaxial fibres, cells dispersed in 2% AlgL were extruded in the middle 
lumen around one filament of SS50 at a rate of 0.05 ml min
-1
, while 2% AlgL without cells 
was extruded through the outer needle at a rate of 0.4 ml min
-1
. The stage speed was set to 
4.8 mm sec
-1
. 
1.3.5 Cell Staining and Imaging 
Calcein acetoxymethyl ester (Calcein AM, Life Technologies, stock concentration: 1 mg ml
-
1
) and propidium iodide (PI, Life Technologies, stock concentration: 1 mg ml
-1
) were used to 
fluorescently label live and dead cells respectively. Staining solutions were prepared 
separately by diluting Calcein AM 1:500 and PI 1:1000 in DPBS (Dulbecco’s phosphate 
buffered saline, Life Technologies). Cells were incubated with Calcein AM staining solution 
for 15 minutes at 37°C, followed by addition of PI staining solution and 5 minutes further 
incubation at room temperature, before the Leica TSC SP5 II confocal microscope and LAS 
AF version 2.6.3.8173 software were used to obtain z-slices and stacks of fluorescently 
labelled cells cultured in 3D gels. Numbers of live and dead cells in each z-slice image were 
counted using the cell counting plugin of ImageJ software. A minimum of 10 images per time 
point, taken at different positions of the 3D structure were analysed. One way ANOVA was 
used to determine significant differences between cell numbers at a confidence level of 0.05.  
1.3.6 Imaging and Microscopy 
Brightfield microscope images were taken using a Leica DM IL LED (Germany) with LAS 
software version 4.0. A confocal microscope (Leica TSC SP5 II) was used to image cells and 
obtain digital micrographs. Scanning electron microscopy images of gel cross-sections were 
obtained after freezing and sectioning the samples in liquid nitrogen. Imaging was performed 
using a low-vacuum JEOL JSM 6490LV. 
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1.4 Results and Discussion 
1.4.1 Controllability, Reproducibility and Flexibility 
To evaluate the controllability and reproducibility of gel fibre diameters resulting from the 
extrusion process, AlgM was extruded around a single Fe65 filament using the coaxial 
spinneret. The extrusion rate was set to 0.3, 0.5 or 0.7 ml min
-1
 respectively with stage speeds 
varying between 2.4 – 21.6 mm sec
-1
. Four stage speeds were used per extrusion event over 
the length of 65 cm, with each speed held for a distance of around 15 cm. To distinguish 
between stage speeds a small low speed phase (stage speed 1.2 mm sec
-1
 over 1 cm) was 
introduced between each speed section (Figure 4A).  
The order in which stage speeds were used along the length of each extrusion event was 
selected randomly to eliminate the potential influence of previous speeds on the resulting gel 
diameter. All combinations of stage speeds and extrusion rates were repeated three times in 
varying combinations of speeds per extrusion event. Once the extrusion was completed, the 
extruded gel was separated into one piece per speed section that was cut into five pieces each. 
Images were taken using the Leica M205A microscope with LAS 4.0 software. On each 
section, the diameter was measured in three locations (towards each end and in the middle) 
using ImageJ. The data of all sections produced using the same parameters were pooled 
together and analysed. 
As expected, the fibre diameter decreases with a reduction in extrusion rate and an increase in 
stage speed, as shown in Figure 4D. The diameters of gels extruded at the same extrusion 
rates follow a power function. At lower stage speeds an increase therefore results in a 
significant reduction of the extruded gel diameter. At higher stage speeds, an increase of the 
speed still results in a reduction of fibre diameter, albeit a much smaller one.  
As can be seen from the small errors, the variation in gel diameter was minimal, averaging 
3 ± 0.9% of the measured diameter. For fibres extruded at a rate of 0.3 ml min
-1
 the deviation 
of diameters was the largest, averaging 3.8 ± 0.7%, while diameters of gels extruded at 
0.5 ml min
-1
 and 0.7 ml min
-1
 showed a deviation of 2.6 ± 0.9% and 2.9 ± 0.5% respectively. 
The difference in consistency of the fibres could be a result of better or poorer match of 
extrusion rates for the spinneret. If the extrusion rates are well matched to the flow area of the 
spinneret, the gel can form evenly around the fibre, without causing disruptions or 
disturbance at the exit of the spinneret, resulting in a more homogenous gel encapsulated 
fibre. Images B – D in Figure 4 show examples of the fibre diameters that can be achieved 
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with the same spinneret, by varying the extrusion rate and stage speed. Without sacrificing 
precision and uniformity, a wide range of desired gel diameters can be produced. 
 
Figure 4: Speed over distance diagram illustrating the method (A) used to produce fibres of different diameters within one extrusion 
event, using four different speeds (S1 – S4 (A)) while applying a constant gel extrusion rate. The short low speed sections between the 
constant speeds are implemented to distinguish between the applied speeds in the finished extrusion as illustrated in B. C: 
Representative images of the resulting gel sections produced in one extrusion event. Gel encapsulated fibre diameter as a function of 
the stage speed (D) at three extrusion rates (0.3, 05 or 0.7 ml min-1). 
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By keeping either the extrusion rate or the stage speed constant and varying the other, gel 
structures with thickness gradients like those shown in Figure 5 can be created. Keeping the 
stage speed constant and applying a variety of extrusion rates throughout the extrusion event 
will lead to the formation of gentle gradients in the overall diameter of the gel fibre. To create 
more abrupt changes in diameter the extrusion rate is kept constant, while the stage speed is 
varied. As shown in Figure 5B the average distance over which the diameter change can be 
created is around 3 mm with an extrusion rate of 0.3 ml min
-1
. Over this distance the fibre 
diameter can be halved or doubled by applying stage speeds with a difference of 15 – 
18 mm sec
-1
. The distance over which the fibre diameter changes can be tailored by changing 
the extrusion rate (lower rates will lead to a shorter distance). The difference in fibre diameter 
is controlled by the difference between the stage speed settings (larger differences will lead to 
a larger change in diameter). 
 
 
Figure 5: Thickness gradients of gel around a 50 µm stainless steel wire resulting from A: varying extrusion rates (0.3 – 0.7 ml min-1, 
distance between measurements 11 mm) used throughout the extrusion process with a constant stage speed (speed 4.8 mm sec-1) and 
B: through a constant extrusion rate (0.3 ml min-1) and varying stage speeds (2.4 – 21.6 mm sec-1). 
 
By using one spinneret and one type of filament, a large variety of fibrous 3D structures can 
be produced in a very controlled fashion. Gel diameters from 0.4 - 2 mm can be fabricated 
readily, in single or multiple extrusion events, creating consistent and gradually or rapidly 
increasing or decreasing sizes. 
 
  
14  
1.4.2 Versatility 
To further expand and explore the versatility of the system a range of spinnerets were studied. 
All spinnerets were custom fabricated (Rame Hart Instrument, USA). Fibre images in Table 2 
show that high complexity of the hydrogel structures can be achieved by changing the 
spinneret design, allowing for positioning of filaments virtually anywhere within the gel. The 
number of encapsulated filaments can be varied, however limitations apply eventually, as the 
spacing between the needles carrying filament needs to be sufficient to allow unimpeded flow 
of gel around each filament. If gels of lower viscosity are used this spacing can be smaller, 
compared to applications where a high viscosity spinning solution is required. The ideal 
design needs to be evaluated on an individual basis taking into consideration the range of 
viscosities of spinning solutions, desired overall diameter of the structure as well as 
coagulation speed of the spinning solution.  
  
  
15  
Table 2 summarises each spinneret’s dimensions and resulting gel structure layouts. The 
overall gel diameters that can be achieved depend on the spinneret dimensions, the extrusion 
rate at which the gel is passed through it and the speed at which the stage is moved.  
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Table 2: Overview of spinneret designs, dimensions (OD: outer diameter, ID: inner diameter), examples of resulting conduit 
structures, parameters for fabrication and spinneret limitations. Extrusion conditions are given in stage speed (mm sec-1) and 
extrusion rate (ml min-1). 
Spinneret 
Needle Gauge 
(OD/ID mm) 
Structure 
Layout 
Example of 3D 
structure 
Materials and 
Extrusion conditions 
Possible Layout and Size 
Spectrum 
 
17 
(1.47/1.07) 
24 
(0.57/0.31)  
 
2% AlgM 
SS50 
11.9/0.5 
1 filament, centered 
100 µm – 2 mm 
 
14 
(2.11/1.60) 
27 
(0.41/0.21)  
 
2% AlgM 
2 PLA115 
2 SS50 
4.8/0.8 
1 - 4 filaments, off centre 
1 – 3 mm 
 
12 
(2.77/2.16) 
27 
(0.41/0.21)  
 
2% AlgM 
5 Fe65 
4.8/1.2 
1 – 5 filaments, off centre 
1.5 – 4 mm 
 
13 
(2.4/1.8) 
27 
(0.41/0.21)  
 
1% AlgL 
4 SS50 
4.8/0.8 
Gellan Gum Microgel 
with PC12 cells 
4.8/0.05 
up to 2 gels 
1 filament, centered 
1 – 4 filaments, off centre 
1.5 – 3.5 mm 
 
17 
(1.5/1.1) 
21 
(0.82/0.51) 
28 
(0.36/0.18) 
 
 
2% AlgL 
4.8/0.4 
0.5% GG + PC12s 
4.8/0.05 
SS50 
 
up to 2 gels 
1 filament, centered 
200 µm – 2 mm 
 
The incorporation of different materials in a controlled fashion was of particular interest 
when developing the system for the fabrication of improved artificial conduits. As a result of 
this, spinnerets with up to three different inlet ports have been custom built, allowing the 
incorporation of fibres and two different gel or liquid compositions. Using this approach, 
cells can be placed into a separate part of the structure, which allows the creation of a better 
suited environment using softer and more porous gels, while the other part of the structure, 
made of a stronger gel, holds the filaments and maintains structural integrity.  
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Filaments made of different materials with a variety of sizes and surface finishes have been 
incorporated into coaxial gel fibres to investigate the versatility as well as limitations of the 
system with regards to the filaments that can be encapsulated. Figure 6 shows a selection of 
filaments, which were successfully embedded into alginate. The lumen diameter of the inner 
needle of the coaxial spinneret has a size of 310 µm, allowing filaments of a maximum cross-
sectional width of 300 µm to be fed through. Single or multiple filaments in a size range of 
50 – 150 µm, of hydrophobic or hydrophilic materials with smooth and rough surfaces were 
embedded into homogenous gel layers. This included SS50 (Figure 6A&B), SS150, PLA150 
(Figure 6C&D), rGO-PPy (Figure 6E&F) and multi-filament CFT (Figure 6G&H). The 
encapsulation of 280 µm Nylon was not successful. During the extrusion process a 
continuous fibrous gel of alginate was formed, however it was not attached to the filament, 
and did not sufficiently encapsulate it. As encapsulation of other hydrophobic filaments was 
achieved, the large diameter in relation to the needle size or a combination of the large 
diameter and the hydrophobic behaviour of the filament are most likely to have prevented the 
encapsulation within gel. This could be addressed by applying a surface treatment to the 
filaments to increase their hydrophilicity or by roughening the surface. Overall a broad range 
of filaments was successfully encapsulated into alginate, including rough, weak filaments 
(rGO-PPy); smooth, elastic filaments (PLA115) and bundles of very fine filaments (CFT), 
which, depending on the filament, introduce properties such as electroactivity, conductivity 
and the potential for controlled drug release into the 3D hydrogel construct.  
 
Figure 6: Filaments of different size, materials and surface structure that have been encapsulated into alginate gel. A&B: SS50, 
11.9 mm sec-1/0.5 ml min-1; C&D: PLA150, 4.8 mm sec
-1/0.5 ml min-1; E&F: rGO-PPy, 4.8 mm sec-1/0.5 ml min-1, G&H: CFT, 
4.8 mm sec-1/0.5 ml min-1.  
The method also allows for a range of filament shapes to be incorporated. Not only filaments 
with a circular cross section and homogenous axial diameter can be encapsulated into gel, but 
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also filaments with an irregular axial diameter as well as fibres with cross sections different 
from circular shape. To demonstrate this capability, three SS50 filaments were manually 
braided before being fed through the coaxial spinneret. 1% AlgM was extruded around the 
braided filaments at an extrusion rate of 0.5 ml min
-1
 and stage speed set to 4.8 mm sec
-1
 
(Figure 7A-B). Incorporation of a hydrophobic filament will lead to the formation of a hollow 
lumen around the filament, resulting from a lack of interaction between the hydrogel and the 
filament. As shown in Figure 7C-D a hydrophobic star-shaped PLA filament was embedded 
into the hydrogel creating a lumen around the filament. The same result was observed for 
PLA filaments with a circular cross section. In contrast no hollow lumen was observed when 
hydrophobic CFT or rGO-PPy were encapsulated, which is most likely a result of the rough 
and uneven surface topography of these filaments. 
To further increase the versatility and areas of application of the extruded structures, 
filaments were encapsulated into alginate and removed following the extrusion process, 
leaving empty or backfilled channels of controlled size and shape (Figure 7E-H). To backfill 
the gel channels the encapsulated filament was removed while the structure was submerged 
into a dispersion of spherical 50 nm sized polypyrrole particles (Figure 7G), or a suspension 
of PC12 cells in cell culture media (Figure 7H).  
The diameter of the channels is dictated by the size of the filament encapsulated. Removal of 
filaments is uncomplicated as long as the matrix material does not adhere to the surface of the 
filament, which makes SS or PLA good materials for removal from hydrogels. SS filaments 
with a diameter of 50 – 150 µm were easily removed from extruded alginate fibres. Channels 
formed by 50 µm filaments show smooth and evenly spaced walls, with the diameter within 
2µm of the filament diameter. When removing the 150 µm filament the resulting channel had 
rougher walls, which were up to 25 µm larger than the filament. As a result of their thickness, 
the 150 µm filaments are stiffer compared to the 50 µm filaments. In the case of the 150 µm 
SS filaments the structure of the gel was dictated by the shape of the filaments as opposed to 
the shape of a gel, i.e. a filament that is not absolutely straight, but instead slightly curved as 
a result of being stored on a spool, will cause the gel to follow the same curve as the filament 
if the filament is stronger than the extruded hydrogel. That is the case when the SS150 
filaments are embedded in the hydrogel. When removing these filaments from the gel the 
channels become distorted as the filament does not bend with the gel during removal. This 
also causes the rougher surface on the inside of the channels, as the relatively sharp end of the 
filament scratches along the walls, leaving them with a rough texture.  
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When backfilling the channels while removing the SS150 filament, these effects were 
observed to be less pronounced. This could be a result of the added lubrication from the 
liquid that is drawn into the channel. Channels produced using SS150 filaments were 
uncomplicated to backfill with aqueous based solutions containing nanoparticles (50 nm) or 
PC12 cells (10 – 20 µm).  
 
Figure 7: Structural versatility of extruded hydrogels containing filaments. A&B: 3 manually braided SS50 filaments embedded into 
2% AlgM (4.8 mm sec
-1/0.4 ml min-1). C&D: PLA+ filament embedded into 2% AlgM (4.8 mm sec
-1/0.5 ml min-1). E&F: 2 SS50 and 2 
SS150 encapsulated into 2% AlgL and removed after extrusion. White arrows indicate the 4 resulting channels. G&H: Backfilling of 
2% AlgL extruded gels by removing the SS150 filament as the structure was submerged into either a dispersion of spherical 50 nm 
sized polypyrrole particles (G) or a suspension of PC12 cells in cell culture media (H). 
The ability to backfill size-controlled channels within the fibrous 3D hydrogel structure opens 
up a different level of versatility. On one hand this method has the benefit of creating very 
homogenously sized channels, as well as much smaller channels than those that can usually 
be achieved in traditional coaxial wet-spinning approaches. These utilise lower concentration 
of coagulant or plain water to inject into the spinning process creating coagulant or water 
filled channels within the gel. Additionally this new technique creates the possibility of 
backfilling the channels with materials or cells that cannot be incorporated into the wet-
spinning process due to incompatibility with the coagulant or the un-crosslinked spinning 
solution. Furthermore, it allows more versatile use of one spinneret configuration as no sealed 
syringe attachment ports are required to inject the solution during the spinning process.  
1.4.3 Cell Compatibility of Filament Encapsulation 
PC12 cells were encapsulated into alginate gel which had been extruded around four SS50 
filaments. The viability of the cells was analysed at three time points after the extrusion by 
selectively staining live and dead cells. As can be seen from the graph in Figure 8A, the 
viability of the cells was above 90% for all time points. The low percentage of dead cells at 
3 h (4.9 ± 1.6%) after the extrusion indicates that the extrusion process itself is cell 
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compatible and does not induce cell death due to unfavourable conditions. After culturing the 
cell-filled construct for 4 days, the viability was still observed to be in a normal range 
(94.2 ± 2.5%), indicating that the cells are sufficiently supplied with nutrients over the period 
tested. As can be observed from the average live cell numbers at each time point, 
proliferation of the cells is limited. A significant increase in cell number was observed after 
24 h compared to 3h with no further increase after 4 days of culturing post fabrication. This is 
a phenomenon that has previously been observed with cells encapsulated in alginate [32]. The 
lack of cell binding motifs and the dense encapsulation lead to inert cell behaviour where 
cells are viable and metabolically active, without showing great adhesion, proliferation or 
differentiation. The lack of attachment to encapsulating gels can be mitigated by chemically 
modifying the alginate gel with cell adhesion-promoting peptides, utilizing a different 
material composition or encapsulating the cells in a different part of the structure using a 
softer, more porous hydrogel. 
 
Figure 8: Alginate encapsulating PC12 cells and four 50 µm stainless steel wires. A: Number of live (green, diagonal lines) and dead 
(red, vertical lines) cells per cm2, with the percentage of dead cells and significant differences in cell number. B: alginate 
encapsulating cells (round dots) and filaments (black lines). 
1.5 Conclusion 
Here we have presented a reliable semi-automated method to create a variety of 3D fibrous 
structures that are based on filaments encapsulated within hydrogels. A wide range of 
filaments (size, shape, material) can be embedded controllably into positions throughout the 
hydrogel. The positioning, number of filament elements and overall size of the structure are 
mostly dependent on the spinneret design, however diameters can be varied greatly by 
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adjusting the extrusion rate of the gel as well as the speed at which the stage translates, 
allowing high controllability while offering versatility within one setup. Further potential 
applications are opened up by removing filaments from the gel, creating precisely sized 
channels which can be left empty or backfilled with other solutions including those 
containing living cells or particles. When used with alginate and a calcium bath as the 
coagulant, this method shows great cytocompatibility with cells extruded straight into the 
structure. 
The method introduced here can address the difficulties of combining all desired properties 
for the “ideal” nerve conduit together in one structure (Figure 9). The overall size of the 
extruded gel is within the range required for use as a conduit and can be varied on demand. 
The porosity of the structure can be tailored by choosing the right material configuration and 
supported by the incorporation of hollow channels within the gel, controlled drug release can 
be achieved by incorporating drug laden fibres or spheres, electrical conductivity and 
electroactivity can be introduced using fibres from organic conducing materials or other 
inherently conducting materials. Physical guidance for regrowing nerve fibres can be 
provided by small encapsulated filaments or channels that are created by the removal of 
filaments. The incorporation of living cells can either be achieved by introducing the cells 
into the gel during the extrusion process, or backfilling them into channels by removing the 
filaments.  
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Figure 9: Schematic of nerve conduit deigns achieved through use of the developed technique. 
Overall, if a lower level of controllability is sufficient for the desired application, this setup 
can be simplified and built up in an inexpensive manner using less sophisticated hardware 
with respect to the stage and syringe pump. Miniaturization of the system is again possible if 
a more portable build is desired. Furthermore we envision that this technique can be of use to 
other fields outside of peripheral nerve regeneration where fibrous hydrogels with controlled 
features and properties are required, including actuation in the field or artificial muscles, 
general microfluidics applications and the broader field of regenerative tissue engineering.  
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